Hydrotestolactone lowers serum oestradiol and PRL levels in normal men: evidence of a role of oestradiol in prl secretion

Clin Endocrinol (Oxf). 1982 Nov;17(5):495-9. doi: 10.1111/j.1365-2265.1982.tb01617.x.

Abstract

The effect on serum PRL levels of lowering serum oestradiol (E2) concentration by short-term administration of an aromatase activity inhibitor, hydrotestolactone (HT), was studied in six healthy male subjects. After HT administration serum E2 levels decreased from 68 +/- 5.8 to 26 +/- 2.5 pmol/l (mean +/- SE, P less than 0.05). These E2 changes were accompanied by a significant decrease in mean 2-h PRL levels from 11.2 +/- 2.1 to 6.5 +/- 1.6 ng/ml mean +/- SE, P less than 0.05). The evaluation of individual percentage change from basal concentrations showed a varying decrease in all subjects. These findings suggest that under physiological conditions E2 may be one of the factors which control blood PRL concentrations in men.

MeSH terms

  • Adult
  • Estradiol / blood*
  • Humans
  • Male
  • Middle Aged
  • Pituitary Gland, Anterior / drug effects
  • Prolactin / blood*
  • Prolactin / metabolism
  • Testolactone / analogs & derivatives*
  • Testolactone / pharmacology
  • Testosterone Congeners / pharmacology*

Substances

  • Testosterone Congeners
  • testololactone
  • Estradiol
  • Testolactone
  • Prolactin